A Major Product Launch Could Paint A Breakout Target On (Nasdaq: QNTM) Early Friday AM

All your attention needs to flood into Quantum BioPharma Ltd. (Nasdaq: QNTM) right now.

StockWireNews A Major Product Launch Could Paint A Breakout Target On (Nasdaq: QNTM) Early Friday AM August 30th Greetings Readers, All your attention needs to flood into Quantum BioPharma Ltd. (Nasdaq: QNTM) right now. After establishing a pre-market high of $6.87, QNTM continues to ride high on breaking news this morning. Take a look: Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon... TORONTO, ON / ACCESSWIRE / August 30, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that highly-anticipated launch of unbuzzd™, a groundbreaking product designed to help individuals recover from the adverse effects of alcohol consumption and prepare for what's next. unbuzzd™ Clear Eyed Citrus Powder Sticks are now available on Amazon(dot)com. ... Read the full article here. Don't forget, QNTM has a low float of approximately 1.23Mn shares. With so few shares available, this means volatility can be explosive. That's why it's critical to pay close attention especially after news like today's launch announcement gets dropped. Listen. Stop what you're doing and get (Nasdaq: QNTM) on your screen before it's too late! ----- Did you catch the license plate on that one? Running like all-get-out, my latest profile, a Sunday night alert, came out swinging for the fences this week. Ending last week at $1.08, the Nasdaq profile soared to a pre-market peak of $2.38, achieving a remarkable 120% (approx.) increase! Late to the party? The excitement continued when the market opened as well. Blasting from an open of $1.53 to a high of $2.31, the breakout star rampaged approximately 50% intraday! Now, pay attention... One of the main reasons we wanted to rehash this latest profile is because its float size resembles the same size as our newest breakout idea. And by that, we mean it's low. This isn't to say this profile will react the same way as my last breakout idea, but low float profiles can have explosive, volatile potential due to so few shares being available in the market. Clocking in with fewer than 2Mn shares in its float, this Nasdaq breakout idea could be on the verge of making a statement if the right type of catalyst comes along. And with the company looking to take on a $7.7Bn market that is ripe for disruption, Wall Street's attention may come on like wildfire. Drop everything and pull up: *Quantum BioPharma Ltd. (Nasdaq: QNTM)* Quantum BioPharma (formerly known as FSD Pharma Inc.) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. And right now, QNTM has several potential catalysts capable of providing a breakout spark. Check these out: #1. A Minuscule Float Could Provide Strong Potential For Explosive Volatility. #2. Another Major Milestone Approaches As Upcoming Amazon Launch Nears. #3. A "Pivotal Moment" On unbuzzd's™ Journey Ahead Of Expected Launch. #4. An Exclusive Option Agreement With The University Of Southern California Highlights Potential To Increase Target Markets. But more on those in a second... UNBUZZD™ - Mental Alertness & Detoxification when Alcohol is Consumed What is UNBUZZD™ in a Nutshell? UNBUZZD™ is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle. Small focus group research indicates UNBUZZD™ reduces BrAC faster than what the body would do naturally. Clinical trials are being planned for further validation. The active ingredients in UNBUZZD™'s formula help restore mental alertness post-alcohol consumption in an average of about 15-30 minutes. Greater Purpose Today's recovery drinks have one goal: to relieve undeniable discomfort after a night out of drinking, infamously known as the "hangover." UNBUZZD™ is more than a hangover cure product. The company's purpose is to re-shape the paradigm by taking an innovative approach to reduce the burden of the aftermath effects of excess alcohol consumption on society. In short, they understand that one person's inebriation can impact countless others. UNBUZZD™ turns the time in your favor. Their formulation was curated through scientific research to expedite recovery from inebriation and to accelerate ethanol metabolism in your body, potentially eliminating any performance concerns today or tomorrow. Quantum BioPharma has licensed UNBUZZD™ to Celly Nutrition Corp. ("Celly Nu") and is entitled to a royalty on the revenue generated by Celly Nu from sales of products created using the technology rights granted under the licensing agreement. Two distinct markets can be served with this technology: 1. Consumer Market (UNBUZZD™) – enjoy alcohol responsibly, work-to-life balance. 2. Hospital Market (REKVRY™) – help an unmet need in the ER and other healthcare settings, reducing costs and burden on healthcare resources/staff. Market Opp. There has yet to be a product backed by strong clinical data that targets reducing BAC (BrAC) levels and Mental Alertness, directly and efficiently. UNBUZZD™ is MORE THAN Hangover Cure Products. Global Hangover Cure Products market size was valued at $2.2Bn in 2023 and expected to reach $7.7Bn by 2032 (Straits Research):

LUCID-MS: Patented new chemical entity (NCE) Lucid-MS is a patented neuroprotective compound that has demonstrated in preclinical models to prevent and reverse myelin degradation, a cause for Multiple Sclerosis, as well as other neurodegenerative diseases and conditions. Lucid-MS has shown excellent results in several animal models. LUCID-MS: Disease Modifying Enabling Remyelination A sampling of the novel qualities of Lucid-MS include: Excellent efficacy in various preclinical animal models Accelerates functional recovery of mouse models of Multiple Sclerosis, preserves myelin, and reduces zonal degradation Does not suppress immune system (non-immunomodulatory) Potential oral administration with easy dosing regimen Quantum BioPharma has completed the dosing of healthy human volunteers for phase-1 clinical trials for Lucid-MS. Today there is no cure for Multiple Sclerosis. Quantum BioPharma ("QNTM") is trying to change this for millions of people. Read more here from the company's not yet updated website. ----- (Nasdaq: QNTM): 5 Potential Breakout Catalysts To Focus On Immediately #1. A Minuscule Float Could Provide Strong Potential For Explosive Volatility. According to the Yahoo Finance website, QNTM has a very small float. In fact, the website reports this profile to have approximately 1.23Mn shares in its float. Why is that important? It's important on one crucial level. Volatility. Could more positive company news midway through 2024 provide a near term spark? ----- #2. Another Major Milestone Approaches As Upcoming Amazon Launch Nears. Quantum BioPharma Provides Update on its In-vest-ment in Celly Nutrition Corp... From the article: John Duffy, CEO of Celly Nutrition, shares his excitement about this significant milestone: "...The successfully completed first production run of unbuzzd™ stick packs is one of the final steps before our August launch." ----- #3. A "Pivotal Moment" On unbuzzd's™ Journey Ahead Of Expected Launch. Quantum BioPharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM) TORONTO, ON / ACCESSWIRE / May 16, 2024 / Quantum BioPharma (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), its new packaging and logo of unbuzzd™ expected to launch this summer, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural processes for metabolizing alcohol and promoting alertness. On May 16, 2024, Celly Nu and SIX+ONE unveil new packaging and logo for unbuzzd™ expected to launch this summer: Toronto, Ontario, May 16, 2024 - Celly Nutrition Corp, makers of unbuzzd™, a pioneering beverage company for innovative, cutting-edge alcohol metabolizing technology for recreational use products, is thrilled to announce the launch of its newly designed packaging and logo, meticulously crafted in collaboration with the renowned branding agency, Six+One. This launch signifies a pivotal moment in unbuzzd's journey in preparation for the expected launch this summer. ... John Duffy, CEO of Celly Nutrition, expressed his excitement about the new branding, stating, "At unbuzzd, we view branding as a crucial element in connecting with our consumers. It goes beyond visual identity; it's about making a meaningful impact. Our design encapsulates this philosophy by merging fun with sophistication, proving that serious products can be both enjoyable and engaging." ... Read the full article here. ----- #4. An Exclusive Option Agreement With The University Of Southern California Highlights Potential To Increase Target Markets. Quantum BioPharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications TORONTO, ON / ACCESSWIRE / June 13, 2024 / Quantum BioPharma (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91), ..., today announces that it entered into an exclusive option agreement with the University of Southern California (USC) to evaluate dietary supplement technology for commercialization. The option agreement, signed June 11, 2024, allows Quantum BioPharma to exclusively evaluate the novel technology for a 6-month term. At the end of this term, Quantum BioPharma will have the option to either extend it for an additional 6 months or to sign an exclusive license for the technology with USC. This novel technology is being evaluated for the potential to further increase the effectiveness of certain ingredients currently present in unbuzzd™. ... "This partnership with Quantum BioPharma underscores USC's longstanding commitment to fostering innovation and translating scientific research into practical solutions that benefit society," said Dr. Erin Overstreet, executive director at the USC Stevens Center for Innovation. "We are excited to be working with Quantum BioPharma, leveraging their expertise in the biopharmaceutical industry, exploring the potential of this novel technology, and enhancing the portfolio of dietary supplement products. Together, we aim to bring forward new advancements that contribute to positive health and well-being for all." ... Read the full article here. ----- QNTM Recap - 4 Potential Breakout Catalysts To Know #1. A Minuscule Float Could Provide Strong Potential For Explosive Volatility. #2. Another Major Milestone Approaches As Upcoming Amazon Launch Nears. #3. A "Pivotal Moment" On unbuzzd's™ Journey Ahead Of Expected Launch. #4. An Exclusive Option Agreement With The University Of Southern California Highlights Potential To Increase Target Markets. ----- Coverage is officially initiated on (Nasdaq: QNTM). Get it on your radar now! Sincerely, Kai Parker StockWireNews (Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)

StockWireNews (stockwirenews . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and SWN is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized fin.ancial advice, are not finan.cial advisors, and our opinions are not suitable for all in.vest.ors. Please review our full disc-laim-er here: www.stockwirenews.net/disclosure An owner of SWN Media LLC owns and operates smallcapfirm . com ("SCF"), owns and operates fierceinvestor . com ("FI"), and owns and operates stockstreetwire . com ("SSW"). From time to time, StockWireNews, SCF, FI, and/or SSW will publicly disseminate information about a company via website, email, SMS and other points of media. Quantum BioPharma Ltd. (Nasdaq: QNTM) previously changed their company name and ticker symbol from FSD Pharma Inc. (Nasdaq: HUGE). Pursuant to an agreement between SWN Media LLC and TD Media LLC, StockWireNews has been hired for a period beginning on 4/21/24 and ending on 4/22/24 to publicly disseminate information about (HUGE) via Website, Email and SMS. SWN Media LLC was paid twenty thousand USD via bank wire transfer. We own zero shares of (HUGE). Pursuant to an agreement between SWN Media LLC and TD Media LLC, StockWireNews has been hired for a period beginning on 8/8/24 and ending on 8/9/24 to publicly disseminate information about (HUGE) via Website, Email and SMS. SWN Media LLC was paid seventeen thousand five hundred USD via bank wire transfer. We own zero shares of (HUGE). Pursuant to an agreement between SWN Media LLC and TD Media LLC, StockWireNews has been hired for a period beginning on 8/29/24 and ending on 8/30/24 to publicly disseminate information about (QNTM) via Website, Email and SMS. SWN Media LLC was paid seventeen thousand five hundred USD via bank wire transfer. We own zero shares of (QNTM). To date we have now been compensated a total of fifty-five thousand USD to disseminate information about (QNTM). A member of SWN Media LLC is also a member of TD Media LLC. Pursuant to an agreement between TD Media LLC and Awareness Consulting Network, TD Media LLC has been hired for a period beginning on 08/29/2024 and ending on 08/30/2024 to publicly disseminate information about (QNTM:US) via digital communications. We have been paid an additional seventy thousand USD. To date we have been paid one hundred fifty-five thousand USD and we own zero shares of (QNTM:US). https://lifewatermedia.com/qntm-disclosure9702/ Unsubscribe Stock Wire News 160 West Camino Real Unit 886 Boca Raton, Florida 33432 United States